Wilson Sonsini Goodrich & Rosati is advising OhmConnect on the transaction. Google Nest Renew announced that it is spinning out from Google and combining with OhmConnect. The...
OhmConnect Merger with Google Nest Renew
Novartis’ Acquisition of DTx Pharma
Wilson Sonsini Goodrich & Rosati is advising DTx Pharma on the transaction. A preclinical-stage biotechnology company, DTx Pharma announced that it has been acquired by Novartis. In addition...
Gilead’s Acquisition of XinThera
Wilson Sonsini Goodrich & Rosati advised XinThera on the transaction. Gilead Sciences announced the acquisition of San Diego-based XinThera, a privately held biotech company. The acquisition...
Amphastar’s $1.075 Billion Acquisition of BAQSIMI from Eli Lilly
Wilson, Sonsini is acting as legal counsel to Amphastar. Kirkland & Ellis and Covington & Burling are acting as legal counsel to Lilly. In an effort...
GE HealthCare’s Acquisition of Caption Health
Wilson Sonsini Goodrich & Rosati advised Caption Health on the acquisition. GE HealthCare, a leading global precision care innovator, announced that it has signed an agreement...
Bruker’s Acquisition of Inscopix
Wilson Sonsini Goodrich & Rosati advised Inscopix on the deal. Bruker Corporation, a developer, manufacturer, and distributor of high-performance scientific instruments and analytical and diagnostic solutions,...
Boston Scientific’s Acquisition of Obsidio
Wilson Sonsini Goodrich & Rosati advised Obsidio on the deal, while Latham & Watkins represented Boston Scientific Corporation. Boston Scientific Corporation announced the acquisition of Obsidio, Inc.,...
EverTrue’s Merger with ThankView
Goodwin Procter advised EverTrue on the deal while Perkins Coie represented ThankVie. EverTrue, a leading advancement software platform, announced its merger with ThankView, the largest personalized video...
Repligen Corporation’s Acquisition of Polymem S.A.
Goodwin Procter advised Repligen Corporation on the deal. Repligen Corporation, a life sciences company focused on bioprocessing technology leadership, announced the acquisition of Polymem S.A., a leading...
BridgeBio Pharma’s $2.45 Billion Collaboration and Licensing Agreement with Helsinn Group
Goodwin Procter LLP advised BridgeBio Pharma, Inc. on the deal. BridgeBio Pharma, Inc. (Nasdaq: BBIO) and its affiliate QED Therapeutics, Inc. announced a global collaboration and licensing...